Ozempic and Wegovy are FDA-approved finished drug products manufactured by Novo Nordisk under current Good Manufacturing Practice standards, reviewed by the FDA for safety, effectiveness, and quality before reaching patients
A Cox proportional hazards model was used to test for non-inferiority against the pre-specified risk margin of 1.3 for the hazard ratio (HR) of the composite of CV death, myocardial infarction (MI), or ischemic stroke (MACE) and if non-inferiority was demonstrated, to test for superiority on the two primary endpoints: 1) the composite of hospitalization for heart failure or CV death, and 2) MACE
While not everyone experiences this side effect, understanding why headaches occur and how to manage them can help patients continue treatment safely
FDA approval is anticipated in late 2026
Based on data generated from our lab, we have evidence that these drugs may be directly stimulating immune cells, which could change the way the immune system responds to challenges. Starting with obesity The research stems from the primary focus of Henrys lab looking at how comorbidities like obesity and aging promote cancer
Staggered administration: Compounds with potentially competing mechanisms or absorption may benefit from temporal separation
